Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Fibroblast cells reveal their ancestry

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 593, 511-512 (2021)

doi: https://doi.org/10.1038/d41586-021-01204-7

References

  1. Koliaraki, V., Prados, A., Armaka, M. & Kollias, G. Nature Immunol. 21, 974–982 (2020).

    Article  PubMed  Google Scholar 

  2. Davidson, S. et al. Nature Rev. Immunol. https://doi.org/10.1038/s41577-021-00540-z (2021).

    Article  Google Scholar 

  3. Croft, A. P. et al. Nature 570, 246–251 (2019).

    Article  PubMed  Google Scholar 

  4. Buechler, M. B. et al. Nature 593, 575–579 (2021).

    Article  Google Scholar 

  5. Gautier, E. L. et al. Nature Immunol. 13, 1118–1128 (2012).

    Article  PubMed  Google Scholar 

  6. Gosselin, D. et al. Cell 159, 1327–1340 (2014).

    Article  PubMed  Google Scholar 

  7. Lavin, Y. et al. Cell 159, 1312–1326 (2014).

    Article  PubMed  Google Scholar 

  8. Korsunsky, I. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.11.426253 (2021).

Download references

Competing Interests

The author has founder’s equity in Mestag Therapeutics, a company that that aims to discover, develop and deliver impactful precision medicines through targeting disease-driving fibroblast subpopulations.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links